X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6316) 6316
Publication (803) 803
Book Review (87) 87
Book Chapter (74) 74
Book / eBook (14) 14
Conference Proceeding (12) 12
Dissertation (6) 6
Newsletter (1) 1
Newspaper Article (1) 1
Reference (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2813) 2813
animals (2555) 2555
index medicus (2444) 2444
male (2125) 2125
pharmacology & pharmacy (1812) 1812
partial agonist (1679) 1679
female (1264) 1264
neurosciences (1208) 1208
rats (1170) 1170
receptor partial agonist (851) 851
adult (827) 827
psychiatry (766) 766
mice (692) 692
dose-response relationship, drug (673) 673
varenicline (668) 668
middle aged (658) 658
partial agonists (575) 575
sustained-release bupropion (555) 555
article (508) 508
clinical neurology (505) 505
ligands (489) 489
schizophrenia (475) 475
biochemistry & molecular biology (453) 453
analysis (445) 445
chemistry, medicinal (438) 438
double-blind (431) 431
efficacy (422) 422
smoking cessation (415) 415
rats, sprague-dawley (411) 411
treatment outcome (393) 393
smoking-cessation (384) 384
aripiprazole (383) 383
smoking cessation - methods (352) 352
pharmacology (348) 348
aged (342) 342
nicotine (340) 340
placebo (336) 336
dopamine (334) 334
double-blind method (318) 318
drug partial agonism (312) 312
smoking (306) 306
activation (302) 302
randomized controlled-trial (299) 299
partial pressure (294) 294
disease models, animal (289) 289
structure-activity relationship (284) 284
time factors (281) 281
rats, wistar (280) 280
research (279) 279
binding (269) 269
epilepsy (269) 269
rat (260) 260
adolescent (250) 250
antagonist (247) 247
brain (244) 244
receptor (236) 236
substance abuse (233) 233
care and treatment (232) 232
health aspects (228) 228
receptors (218) 218
smoking cessation programs (212) 212
drug therapy (211) 211
in vitro techniques (210) 210
young adult (204) 204
in-vivo (201) 201
models, molecular (194) 194
antagonists (193) 193
serotonin (189) 189
nicotinic agonists - therapeutic use (188) 188
physiology (188) 188
benzazepines - therapeutic use (187) 187
quinoxalines - therapeutic use (187) 187
antipsychotic agents - therapeutic use (186) 186
behavioral sciences (186) 186
chemistry, organic (186) 186
expression (183) 183
safety (182) 182
partial thromboplastin time (180) 180
physiological aspects (176) 176
neurology (174) 174
tobacco (173) 173
pharmacotherapy (171) 171
rodents (169) 169
medicine & public health (168) 168
piperazines - pharmacology (168) 168
cell biology (165) 165
clinical trials (165) 165
in-vitro (165) 165
drugs (162) 162
nicotinic agonists - pharmacology (162) 162
binding sites (161) 161
medicine, general & internal (161) 161
placebo-controlled trial (161) 161
gaba (158) 158
schizophrenia - drug therapy (157) 157
brain - metabolism (156) 156
rat-brain (154) 154
piperazines - therapeutic use (153) 153
dependence (152) 152
depression (152) 152
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6291) 6291
Japanese (46) 46
German (30) 30
Spanish (20) 20
French (15) 15
Italian (6) 6
Chinese (5) 5
Polish (4) 4
Turkish (4) 4
Portuguese (3) 3
Russian (3) 3
Hungarian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


NATURE, ISSN 0028-0836, 01/2011, Volume 469, Issue 7329, pp. 241 - 244
beta-adrenergic receptors (beta ARs) are G-protein-coupled receptors (GPCRs) that activate intracellular G proteins upon binding catecholamine agonist ligands... 
CRYSTALLIZATION | AMINO-ACID | ACTIVATION | LIGAND-BINDING | BETA-ADRENERGIC-RECEPTORS | PROTEIN-COUPLED RECEPTOR | CRYSTAL-STRUCTURE | MULTIDISCIPLINARY SCIENCES | CRYSTALLOGRAPHY | HIGH-AFFINITY BINDING | BETA-ADRENERGIC RECEPTOR | Dobutamine - metabolism | Hydroxyquinolines - chemistry | Catecholamines - metabolism | Albuterol - pharmacology | Amphetamines - pharmacology | Adrenergic beta-1 Receptor Antagonists - pharmacology | Crystallography, X-Ray | Adrenergic beta-1 Receptor Agonists - chemistry | Structure-Activity Relationship | Receptors, Adrenergic, beta-1 - chemistry | Adrenergic beta-1 Receptor Agonists - pharmacology | Turkeys | Adrenergic beta-1 Receptor Antagonists - chemistry | Drug Design | Adrenergic beta-1 Receptor Antagonists - metabolism | Dobutamine - chemistry | Isoproterenol - chemistry | Binding Sites | Hydroxyquinolines - pharmacology | Amphetamines - chemistry | Drug Partial Agonism | Albuterol - metabolism | Hydroxyquinolines - metabolism | Isoproterenol - metabolism | Models, Molecular | Receptors, Adrenergic, beta-1 - metabolism | Serine - chemistry | Serine - metabolism | Dobutamine - pharmacology | Animals | Hydrogen Bonding | Amphetamines - metabolism | Isoproterenol - pharmacology | Protein Stability - drug effects | Albuterol - chemistry | Ligands | Protein Conformation | Adrenergic beta-1 Receptor Agonists - metabolism
Journal Article
2001, ISBN 9780195139402, xiv, 248
In "Caring for Patients at the End of Life: Facing an Uncertain Future Together", the author uses his wide range of clinical experience caring for severely ill... 
Physician and patient | Terminal care | Palliative Care | Palliative treatment | Attitude to Death | methods | Nursing & Ancillary Services | palliative medicine | Clinical experience | Clinicians | Partnership | Medical humanism | Palliative care | Values | Non-abandonment | Near-death experience | Bad news | Patients
Book
Journal Article
European Neuropsychopharmacology, ISSN 0924-977X, 2010, Volume 20, Issue 8, pp. 582 - 593
Abstract Partial D2/3 dopamine (DA) receptor agonists provide a novel approach to the treatment of the motor symptoms of Parkinson's disease (PD) that may... 
Internal Medicine | Psychiatry | Parkinson's | partial agonist | agonist | Dopamine D | MPTP | Pardoprunox (SLV308) | 5-HT
Journal Article
Journal Article
Journal Article
Bioorganic & Medicinal Chemistry Letters, ISSN 0960-894X, 09/2013, Volume 23, Issue 18, pp. 5082 - 5085
Journal Article
Frontiers in Neuroscience, ISSN 1662-4548, 2015, Volume 9, p. 125
Background: Application of transcranial random noise stimulation (tRNS) between 0.1 and 640 Hz of the primary motor cortex (M1) for 10 min induces a persistent... 
Transcranial magnetic stimulation (TMS) | D-cycloserine (D-CYC: partial NMDA receptor agonist) | Dextromethorphan (DMO: NMDA receptor antagonist) | transcranial random noise stimulation (tRNS) | Carbamazepine (CBZ: sodium channel blocker) | Lorazepam (LOR: GABA A receptor agonist) | Ropinirole (ROP: D 2 /D 3 receptor agonist) | Transcranial direct current stimulation (tDCS) | carbamazepine (CBZ: sodium channel blocker) | CELLS | ACTIVATION | EXCITATION | NEUROPLASTICITY | HUMANS | NEUROSCIENCES | CORTICAL EXCITABILITY | HUMAN MOTOR CORTEX | CONSOLIDATION | ropinirole (ROP: D-2/D-3 receptor agonist) | transcranial magnetic stimulation (TMS) | NONINVASIVE BRAIN-STIMULATION | dextromethorphan (DMO: NMDA receptor antagonist) | transcranial direct current stimulation (tDCS) | MODULATION | lorazepam (LOR: GABA(A) receptor agonist) | Dopamine | Transcranial magnetic stimulation | γ-Aminobutyric acid A receptors | Glutamic acid receptors (ionotropic) | Noise | Cortex | Dopamine D3 receptors | Excitability | N-Methyl-D-aspartic acid receptors | Dextromethorphan | Cortex (motor) | Cycloserine | Benzodiazepines | Carbamazepine | Neurophysiology | Electrical currents | Electrodes | Morphology | Agonists | Lorazepam | Magnetic fields | Electric fields | ropinirole (ROP: D2/D3 receptor agonist) | lorazepam (LOR: GABAA receptor agonist)
Journal Article
Journal Article
Synapse, ISSN 0887-4476, 12/2006, Volume 60, Issue 8, pp. 599 - 608
Present Parkinson's disease treatment strategies are far from ideal for a variety of reasons; it has therefore been suggested that partial dopamine receptor... 
receptor binding | partial agonist | serotonin | Parkinson's disease | 5‐HT1A | neurochemistry | Neurochemistry | Partial agonist | Serotonin | 5-HT | Receptor binding | Serotonin 5-HT1 Receptor Agonists | Benzoxazoles - pharmacology | Rats, Wistar | Humans | Receptors, Dopamine D3 - metabolism | Receptor, Serotonin, 5-HT1A - genetics | Serotonin Receptor Agonists - isolation & purification | Male | Lisuride - pharmacology | Parkinson Disease - drug therapy | Piperazines - chemistry | Receptors, Dopamine D2 - metabolism | Recombinant Fusion Proteins - metabolism | Serotonin Receptor Agonists - pharmacology | Benzoxazoles - isolation & purification | Brain - metabolism | Dose-Response Relationship, Drug | Receptors, Dopamine D3 - genetics | Lisuride - analogs & derivatives | Molecular Structure | Parkinson Disease - metabolism | Radioligand Assay | Cyclic AMP - metabolism | Receptor, Serotonin, 5-HT1A - metabolism | CHO Cells | Dopamine Agonists - pharmacology | Cricetinae | Binding, Competitive - physiology | Colforsin - pharmacology | Brain - physiopathology | Receptors, Dopamine D2 - agonists | Serotonin Receptor Agonists - chemistry | Rats | Parkinson Disease - physiopathology | Piperazines - isolation & purification | Piperazines - pharmacology | Receptors, Dopamine D2 - genetics | Binding, Competitive - drug effects | Brain - drug effects | Dopamine Agonists - isolation & purification | Receptors, Dopamine D3 - agonists | Guanosine 5'-O-(3-Thiotriphosphate) - metabolism | Animals | Benzoxazoles - chemistry | Drug Interactions - physiology | Recombinant Fusion Proteins - genetics | Quinpirole - pharmacology | Dopamine Agonists - chemistry
Journal Article